214 related articles for article (PubMed ID: 29302747)
1. Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.
Çolak Sivri R; Bilgiç A; Kılınç İ
Eur Child Adolesc Psychiatry; 2018 Aug; 27(8):977-984. PubMed ID: 29302747
[TBL] [Abstract][Full Text] [Related]
2. Cortisol and Brain-Derived Neurotrophic Factor Levels Prior to Treatment in Children With Obsessive-Compulsive Disorder.
Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Alaca R
J Clin Psychiatry; 2016 Jul; 77(7):e855-9. PubMed ID: 27314567
[TBL] [Abstract][Full Text] [Related]
3. A cytokine study of adult patients with obsessive-compulsive disorder.
Fontenelle LF; Barbosa IG; Luna JV; de Sousa LP; Abreu MN; Teixeira AL
Compr Psychiatry; 2012 Aug; 53(6):797-804. PubMed ID: 22300901
[TBL] [Abstract][Full Text] [Related]
4. Increased serum brain-derived neurotrophic factor and adrenocorticotropic hormone levels are associated with obsessive compulsive disorder in medication‑free children.
Bilgiç A; Sertdemir M; Kılınç İ; Akça ÖF
Eur Child Adolesc Psychiatry; 2022 Feb; 31(2):325-335. PubMed ID: 33389158
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophic factors in obsessive-compulsive disorder.
Fontenelle LF; Barbosa IG; Luna JV; Rocha NP; Silva Miranda A; Teixeira AL
Psychiatry Res; 2012 Oct; 199(3):195-200. PubMed ID: 22494702
[TBL] [Abstract][Full Text] [Related]
6. Blood levels of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha and cognitive functions in patients with obsessive compulsive disorder.
Karagüzel EÖ; Arslan FC; Uysal EK; Demir S; Aykut DS; Tat M; Karahan SC
Compr Psychiatry; 2019 Feb; 89():61-66. PubMed ID: 30594753
[TBL] [Abstract][Full Text] [Related]
7. Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder.
Rao NP; Venkatasubramanian G; Ravi V; Kalmady S; Cherian A; Yc JR
Psychiatry Res; 2015 Oct; 229(3):949-52. PubMed ID: 26187339
[TBL] [Abstract][Full Text] [Related]
8. Serum zonulin and claudin-5 levels in children with obsessive-compulsive disorder.
Işık Ü; Aydoğan Avşar P; Aktepe E; Doğuç DK; Kılıç F; Büyükbayram Hİ
Nord J Psychiatry; 2020; 74(5):346-351. PubMed ID: 31961248
[No Abstract] [Full Text] [Related]
9. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
[TBL] [Abstract][Full Text] [Related]
10. The relationship between Toxoplasma gondii IgG antibodies and generalized anxiety disorder and obsessive-compulsive disorder in children and adolescents: a new approach.
Akaltun İ; Kara SS; Kara T
Nord J Psychiatry; 2018 Jan; 72(1):57-62. PubMed ID: 28990850
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder.
Rodríguez N; Morer A; González-Navarro EA; Serra-Pages C; Boloc D; Torres T; García-Cerro S; Mas S; Gassó P; Lázaro L
J Neuroinflammation; 2017 Dec; 14(1):261. PubMed ID: 29284508
[TBL] [Abstract][Full Text] [Related]
12. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.
Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M
Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880
[TBL] [Abstract][Full Text] [Related]
13. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.
Wang Y; Zhang H; Li Y; Wang Z; Fan Q; Yu S; Lin Z; Xiao Z
J Affect Disord; 2015 Nov; 186():7-12. PubMed ID: 26209750
[TBL] [Abstract][Full Text] [Related]
14. Comparing family accommodation in pediatric obsessive-compulsive disorder, anxiety disorders, and nonanxious children.
Lebowitz ER; Scharfstein LA; Jones J
Depress Anxiety; 2014 Dec; 31(12):1018-25. PubMed ID: 24677578
[TBL] [Abstract][Full Text] [Related]
15. Severe symptoms predict salivary interleukin-6, interleukin-1β, and tumor necrosis factor-α levels in children and youth with obsessive-compulsive disorder.
Westwell-Roper C; Best JR; Naqqash Z; Au A; Lin B; Lu C; Shao L; Beasley CL; Stewart SE
J Psychosom Res; 2022 Apr; 155():110743. PubMed ID: 35190349
[TBL] [Abstract][Full Text] [Related]
16. 8-F2-isoprostane, thioredoxin and thioredoxin reductase levels in children with obsessive-compulsive disorder.
Bilgiç A; Çolak Sivri R; Kılınç İ
Nord J Psychiatry; 2018 Oct; 72(7):484-488. PubMed ID: 29927677
[TBL] [Abstract][Full Text] [Related]
17. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.
Kawano A; Tanaka Y; Ishitobi Y; Maruyama Y; Ando T; Inoue A; Okamoto S; Imanaga J; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Akiyoshi J
Psychiatry Res; 2013 Aug; 209(1):85-90. PubMed ID: 23266021
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of brain-derived neurotrophic factor in drug-naïve obsessive-compulsive patients: a case-control study.
Maina G; Rosso G; Zanardini R; Bogetto F; Gennarelli M; Bocchio-Chiavetto L
J Affect Disord; 2010 Apr; 122(1-2):174-8. PubMed ID: 19664825
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor (BDNF) plasma levels in drug-naïve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients.
Wang Y; Mathews CA; Li Y; Lin Z; Xiao Z
J Affect Disord; 2011 Sep; 133(1-2):305-10. PubMed ID: 21616543
[TBL] [Abstract][Full Text] [Related]
20. Serum Cytokine Profiles of Children with Obsessive-Compulsive Disorder Shows the Evidence of Autoimmunity.
Şimşek Ş; Yüksel T; Çim A; Kaya S
Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27207913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
